KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) EBT (2016 - 2026)

Nu Skin Enterprises' EBT history spans 17 years, with the latest figure at -$63.8 million for Q4 2025.

  • On a quarterly basis, EBT rose 47.04% to -$63.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $114.2 million, a 148.05% increase, with the full-year FY2025 number at $114.2 million, up 148.05% from a year prior.
  • EBT hit -$63.8 million in Q4 2025 for Nu Skin Enterprises, down from $16.0 million in the prior quarter.
  • Over the last five years, EBT for NUS hit a ceiling of $134.6 million in Q1 2025 and a floor of -$131.6 million in Q2 2024.
  • Historically, EBT has averaged $5.7 million across 5 years, with a median of $13.9 million in 2023.
  • Biggest five-year swings in EBT: crashed 1391.21% in 2024 and later skyrocketed 12125.34% in 2025.
  • Tracing NUS's EBT over 5 years: stood at -$26.9 million in 2021, then plummeted by 49.26% to -$40.2 million in 2022, then soared by 123.2% to $9.3 million in 2023, then crashed by 1391.21% to -$120.4 million in 2024, then surged by 47.04% to -$63.8 million in 2025.
  • Business Quant data shows EBT for NUS at -$63.8 million in Q4 2025, $16.0 million in Q3 2025, and $27.4 million in Q2 2025.